Drug-resistant tuberculosis may be under-diagnosed, says genomic analysis in southern Mozambique

A proportion of patients with drug-resistant tuberculosis (TB) receive ineffective treatment due to misdiagnosis by rapid molecular tests, according to a genomic analysis carried out in southern Mozambique and co-led by the Barcelona Institute for Global Health (ISGlobal), a center supported by “la Caixa” Foundation, and the Institute of Biomedicine in Valencia (IBV), from the Spanish National Research Council (CSIC).